Join a highly interactive, engaging symposium featuring interactive audience questions that focus on the heterogeneous nature of obesity and its link with other comorbid conditions, with discussion from expert faculty.

The program will consider obesity as a multifactorial disease that requires continual advances in care to improve weight and cardiometabolic outcomes. Faculty will review novel treatment pathways that take into consideration the biology of obesity and the role of the liver and other metabolic organs in obesity.

Expert-led, knowledge-driven presentations will answer questions around the complex pathophysiological pathways involved in obesity, discuss the need for newer therapies, and focus on clinical data supporting a role for new and emerging agents to improve broader metabolic outcomes in people with obesity.

CME Accreditation and Credit Designation Statements

The Institute for Medical and Nursing Education, Inc. (IMNE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. IMNE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial support acknowledgment

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Co-provided by International Medical Press Ltd. and the Institute for Medical and Nursing Education, Inc.

Lee Kaplan MD, PhD

Director, The Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital

Appearances